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In tick salivary glands, several genes are induced dur-
ing the feeding process, leading to the expression of new
proteins. These proteins are typically secreted in tick
saliva and are potentially involved in the modulation of
the host immune and hemostatic responses. In a previ-
ous study, the construction and the analysis of a sub-
tractive library led to the identification of Ixodes ricinus
immunosuppressor (Iris), a novel protein, differentially
expressed in I. ricinus salivary glands during the blood
meal. In the present study, the data strongly suggest
that this protein is secreted by tick salivary glands into
the saliva. In addition, Iris is also found to modulate T
lymphocyte and macrophage responsiveness by induc-
ing a Th2 type response and by inhibiting the produc-
tion of pro-inflammatory cytokines. In conclusion, these
results suggest that Iris is an immunosuppressor, which
might play an important role in the modulation of host
immune response.
In contrast to most hematophagous arthropods that feed to
repletion rapidly, Ixodid female ticks feed for an extended
period of over 2 weeks (1).
Completion of the blood meal is dependent on the relation-
ships of ticks with host species (2). Resistance to tick infesta-
tion implicates both innate and acquired immunity and is
characterized by reduced feeding, molting, and mating capabil-
ities that may lead to the death of the parasite. Acquired
immunity of resistant hosts is mediated by a polarized Th1-
type immune response, involving IFN-1 production and de-
layed type hypersensitivity reaction (3, 4).
Some hosts are unable to counteract the tick infestation (4).
Indeed, during their blood meal, ticks circumvent host defenses
via pharmacologically active components secreted in their sa-
liva. These factors of major importance for tick survival can
modulate innate and acquired immunity. In this way, the leu-
kocyte responsiveness is modified during tick feeding (5). For
example, cytokine production is modulated, inducing a polar-
ized Th2 immune response (4, 6). Therefore, the complex tick-
host molecular interactions can be considered as a competition
between host defenses raised against the parasite and the tick
evasion strategies, facilitating feeding for an extended period.
Although there is extensive information about the effects of
tick bioactive factors on host immune response, little is known
about the mechanisms of their actions. However, it has been
observed that a wide range of new proteins are expressed
during the blood meal (7). Several of them might be essential
for the completion of the tick feeding process. At the present
time, only a few of them have been characterized (8, 9).
To identify cDNAs encoding proteins specifically expressed
during the blood meal in the salivary glands of I. ricinus female
ticks, a representational difference analysis subtractive library
was set up using mRNAs extracted from salivary glands of
unfed and 5-day-fed female I. ricinus ticks. One clone, formerly
named seq24 (GenBank accession no. AJ269658), was se-
lected for further characterization of its recombinant protein
(previously Seq24/MBP and Seq24/His), because of its similar-
ity to the pig leukocyte elastase inhibitor (10). Elastase inhib-
itors have been identified in many mammalian species but also
in arthropods like the leech Hirudo nipponia (11). The immu-
nological properties of such inhibitors are not clearly estab-
lished. However, these proteins are secreted by human macro-
phages, monocytes, and neutrophils (12). Recently, it has been
also shown that the elastase inhibitor mRNA is abundantly
expressed during delayed type hypersensibility responses (13).
Based on the results, we have decided to call this tick protein
“Iris” for “I. ricinus immunosuppressor.”
In this study, we describe the characterization of Iris. We
demonstrate that Iris is induced during the tick feeding process
but is also secreted into the saliva. Moreover, the characteriza-
tion of its properties shows that Iris has the unique capacity to
modulate both the innate and the acquired immunity of the host.
EXPERIMENTAL PROCEDURES
Biological Materials
Unfed and 5-day-fed tick salivary gland proteinic extracts were ob-
tained from 300 and 70 I. ricinus salivary glands, respectively. These
salivary glands were crushed for 10 min using a potter and a pestle in
extraction buffer (1 PBS, pH 7.4, 10 mM EDTA, 1 mM 4-(2-amino-
ethyl)-benzenesulfonyl fluoride; Sigma-Aldrich, Bornem, Belgium). The
samples were centrifuged at 10,000 g for 8 min, and the supernatants
were stored at 20 °C.
Saliva was collected from ticks fed for 5 days on the ears of a rabbit.
Engorging ticks were removed and washed, and a 0.2% dopamine
(Sigma-Aldrich) solution in 1 PBS, pH 7.2, was injected in the tick
body. A finely drawn capillary tube fitted over the mouthparts of each
tick enabled us to collect saliva.
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Production of Recombinant Iris (rIris) Protein in Bacterial and
Mammalian Expression Systems
Recombinant Iris (rIris) protein was obtained as described by Leb-
oulle et al. (10). Briefly, iris cDNA was recovered by analyzing a repre-
sentational difference analysis subtractive library. This library was
constructed as described by Hubank and Schatz (14) by using mRNA
populations extracted from unfed and 5-day-engorged tick salivary
glands. The complete iris cDNA sequence was recovered by performing
the rapid amplification of cDNA ends methodology as described by
Frohman (15). The recombinant rIris/MBP protein was expressed in
Escherichia coli by using the pMALC2-E vector (New England Biolabs,
Hitchin, United Kingdom) containing MBP fusion partner. The rIris/
His protein was expressed in CHO-KI cells by using the
pCDNA3.1/V5-His A vector containing the Epitag V5/His6 tag fusion
partner (10).
The rIris/His protein was purified in batch by nickel-chelate chroma-
tography (nickel-NTA superflow resin; Qiagen, Hilden, Germany), ac-
cording to manufacturer’s instructions. Different buffers were used to
purify the rIris/His protein: the lysis buffer (1 PBS, 500 mM NaCl,
0.1% Zwittergent 3.12, pH 7.5); the washing buffer (1 PBS, 500 mM
NaCl, 0.1% Zwittergent 3.12, 17.25 mM imidazole, pH 7.5), and the
elution buffer (1 PBS, 500 mM NaCl, 0.1% Zwittergent 3.12, 103 mM
imidazole, pH 7.5). The eluate was dialyzed (in a 7,000-Da cut-off
membrane) in 1 PBS, 500 mM NaCl, pH 7.5. The concentration of the
protein was evaluated on a Coomassie Blue-stained acrylamide gel, at
10 ng/l (250 nM), by comparison with known quantities of BSA. This
result was confirmed by performing a micro bicinchoninic acid (BCA)
protein assay (Pierce; data not shown).
Immunodetection of Iris
To examine the expression of native proteins in salivary glands and
to detect rIris/His, the same quantities of fed and unfed tick salivary
glands and a rIris/His sample were subjected to SDS-PAGE and trans-
ferred onto nitrocellulose membranes. The membranes were probed
with diluted sera directed against rIris/MBP (1:1,000) (10) and revealed
with nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate.
Confocal Microscopy
I. ricinus salivary glands were dissected from unfed, 3-day-fed, or
5-day-fed ticks and immobilized on silanated slides (Bio-Rad, Nazareth
EKE, Belgium). Salivary glands were fixed in a 4% paraformaldehyde
solution. After a treatment with 0.5% Triton X-100, the samples were
incubated in 1 PBS containing 5% fetal calf serum. The anti-rIris/
MBP serum was used at a 1:10 dilution, and the secondary antibody, a
fluorescein isothiocyanate anti-mouse IgG (HL) (ICN, Asse-Relegem,
Belgium) at a 1:32 dilution. The slides were mounted in Vectashield
mounting medium (Vector Lab, Peterborough, United Kingdom) and
observed with a Leica confocal laser microscope using a Leica TCS 4D
operating system (Leica, Wetzlar, Germany).
Preparation of rIris/His Cellular Extract and rIris Negative
Control (NEG) Extracts Used in Activity Tests
CHO-KI cells expressing rIris/His protein, obtained from a confluent
culture in five 150-cm2 flasks, were resuspended in 1 ml of RPMI 1640
complete medium. The sample was frozen and thawed three times
before being centrifuged at 50,000  g for 1 h at 4 °C. The supernatant
was recovered and used in the different activity tests. NEG was a
proteinic extract of CHO-KI cells resistant to G418 that do not express
the recombinant protein and was prepared as the rIris/His extract. The
concentration of rIris/His in the cellular extract was evaluated at 4
ng/l (100 nM), by comparing rIris/His contained in cellular extracts
and purified rIris/His, on Western blot revealed with anti-V5 antibody
(Invitrogen, Groningen, The Netherlands). The toxicity of the different
samples for human peripheral blood mononuclear cells (PBMCs) was
evaluated by using the 7-amino-actinomycin D viability dye (Immuno-
tech, Marseille, France), according to manufacturer’s instructions.
Cell Culture
Naive Balb/c Spleen Cells—A suspension of spleen cells (SC) was
isolated from naive Balb/c mice. 106 lymph node cells/well were culti-
vated with serial dilutions of rIris/His or NEG cellular extracts for 2 h
in 100 l of complete culture medium containing RPMI 1640 (Invitro-
gen, Basel, Switzerland) supplemented with 10% fetal calf serum (v/v),
2 mM L-glutamine, 1 mM sodium pyruvate, 1 mM nonessential amino
acids (Sigma), 0.05 mM mercaptoethanol, 100 units/ml penicillin/strep-
tomycin (Invitrogen), and 25 g/ml Funigizone (Invitrogen). Cells were
then stimulated with 1 g/ml concanavalin A (ConA) in a final volume
of 200 l for 15 h. 1 Ci/well [3H]thymidine (Amersham Biosciences,
Inc., Amersham, United Kingdom) was added 24 h before harvesting
the cells. Tritiated thymidine incorporation was determined by liquid
FIG. 1. Confocal microscopy of fe-
male I. ricinus salivary glands. A, neg-
ative control corresponding to 5-day-fed
tick salivary glands incubated only with
the secondary antibody. B–D, unfed (B),
3-day-fed (C), and 5-day-(D) tick salivary
glands incubated with anti-rIris/MBP
serum.
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scintillation counting. Results show the means ( S.D.) of duplicate
rIris/His or NEG stimulated wells realized in two independent experi-
ments. Means of ConA-unstimulated wells were previously subtracted.
Naive Human PBMCs—Experiments were realized with PBMCs,
obtained from 5 different donors, used separately. PBMCs were resus-
pended in RPMI 1640 medium supplemented with 10% fetal calf serum
(v/v), L-glutamine 2 mM, penicillin-streptomycin (100 units/ml), and
IL-2 (20 units/ml). 2  106 cells were pre-cultivated in 1 ml of culture
medium. Cells were then diluted at different concentrations in 96-well
plates (2  105 cells/100 l for protein purified derivative (PPD) stim-
ulation, 5  104 cells/100 l for LPS stimulation for the ELISPOT
technique, and 2  105 cells/100 l for the ELISA technique). Finally,
PBMCs were incubated, for 72 h at 37 °C, with different dilutions of
rIris/His or NEG cellular extract or anti-rIris/MBP serum and the
different activators: phytohemagglutinin A (PHA) (at a final concentra-
tion of 1 g/ml), LPS (1 g/ml), anti-CD3/CD28 monoclonal antibody
(500 ng/ml), PMA/CD28 (PMA at 25 ng/ml, CD28 at 500 ng/ml), and
PPD (5 g/ml).
Detection of Cytokines
ELISPOT Assay—96-well nitrocellulose bottom-coated plates (Mul-
tiscreen-HA Mahan, Millipore, Brussels, Belgium) were coated with
coating antibodies directed against IFN- (clone C1-D16 MAB 1-D1K,
Nodia, Antwerp, Belgium) and IL-10 (clone JES3-9D7, PharMingen,
San Diego, CA). Cells were stimulated with PHA or LPS and rIris/His
or NEG cellular extracts for 72 h at 37 °C. Supernatants were recovered
and stored at 20 °C. The cytokines were detected, in the 96-well
plates, with biotinylated anti-IFN- antibody (clone JES3–5A10 MAB
7-B6-1, Nodia) and anti-IL10 antibody (clone JES3-12G8, PharMingen)
diluted in PBS, 0.25% Tween (1 g/ml). Finally, the captured antibodies
were revealed with extravidin peroxidase and 3-amino-9-ethyl carba-
zole substrate (Sigma-Aldrich). Results show the mean of triplicate
wells ( S.D.). Means of unstimulated wells were previously sub-
tracted. The rIris/His and NEG protein extracts do not affect the cell
viability (data not shown).
ELISA Technique—Cytokine-specific ELISAs were realized using
the Flexia human kit (BIOSOURCE, Nivelles, Belgium) for the detec-
tion of IFN-, IL-10, TNF-, IL-6, IL-1, and IL-8, and the IL-5 kit
(Endogene, Woburn, MA) for the detection of IL-5. The assays were
carried out using manufacturer’s instructions and were revealed using
3,3,5,5-tetramethylbenzidine substrate. The concentration of the dif-
ferent cytokines in the experimental samples (pg/ml) was calculated
against a standard curve generated with recombinant cytokines. Re-
sults show the mean of rIris/His or NEG cellular extract-stimulated
wells realized in five independent experiments ( S.D.). Means of
unstimulated wells were previously subtracted.
Statistical Analysis
The significance of the differences obtained between NEG and rIris/
His-treated groups was evaluated by Student’s t test using the pooled or
Satterthwaite method.
RESULTS
Detection of Iris in I. ricinus Salivary Glands and Saliva
Immune sera recovered from mice immunized with rIris/
MBP (formerly Seq24/MBP) were used to detect the native Iris
protein in the salivary glands and saliva from unfed or en-
gorged female I. ricinus ticks. Iris was revealed by Western blot
in tick saliva at a molecular mass of 43 kDa (data not shown).
By using confocal microscopy, it was found in 3-day-fed and,
more abundantly, in 5-day-fed tick salivary glands on the ex-
ternal surface of salivary acini, within the cells and also in the
acini’s light, but was not detected in unfed tick salivary glands
(Fig. 1). These results suggest that the expression of Iris is
induced in the salivary glands during the tick feeding process
and that Iris is secreted in tick saliva.
Characterization of the Immunomodulatory Properties of
Iris
Based on its homology to a leukocyte elastase inhibitor, the
immunomodulatory properties of Iris were examined by using
different activity tests that were mainly performed with soluble
proteinic extracts of CHO-KI cells expressing rIris/His (former-
ly named Seq24/His) at a concentration of 4 ng/l (100 nM).
Proteinic extracts of CHO-KI cells, which do not express rIris/
His, were used as NEG.
In Vitro Proliferation of Balb/c Naive Spleen Cells—The
proliferation of naive Balb/c SC was analyzed in vitro by pre-
incubating them with various dilution (1:6.25 to 1:50) of rIris/
His cellular extracts, followed by stimulation with ConA. As
shown on Fig. 2, the proliferative response of SC was strongly
diminished (81% of inhibition at a 1:6.25 dilution) in a dose-
dependent manner. The negative control had no significant
effect on ConA-stimulated SC (average inhibition of 15%); even
if it inhibited by 25% the SC proliferation at a 1:6.25 dilution.
In Vitro Stimulation of Human PBMCs—The effect of rIris/
His on cytokine production was studied on PBMCs stimu-
lated with different activators. The number of PBMCs secret-
ing IFN- and IL-10, after stimulation either with LPS or
PHA, was assayed by the ELISPOT technique (Fig. 3). After
PHA stimulation, in presence of rIris/His cellular extract, a
reduced number of PBMCs (more than 80%) secreted IFN-,
whereas the number of cells producing IL-10 remained un-
changed. Furthermore, the NEG protein extract had no effect
on the production of both cytokines by PHA-stimulated PB-
MCs. In contrast, after LPS stimulation, no difference in the
number of cells producing IFN- was observed between PB-
MCs incubated with rIris/His and the NEG cellular extract.
On the other hand, rIris/His extract enhanced by 400% the
number of PBMCs expressing IL-10, whereas stimulation
with NEG cellular extract did not enhance the number of
cells producing IL-10.
The effect of rIris/His cellular extract (used at a 1:5 dilution)
on the production of cytokines (IFN-, IL-8, IL-10, IL-6, TNF-,
FIG. 2. Balb/c spleen cells stimu-
lated with ConA. SC were incubated
only with ConA (N.S.) or with different
dilutions of rIris/His and NEG cellular
extracts. Tritiated thymidine incorpora-
tion was determined by liquid scintilla-
tion counting (103 cpm  S.D.).
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and IL-1) by PBMCs stimulated with a set of activators (PHA,
CD3/CD28, LPS, and PPD) was also evaluated by ELISA
(Table I). The results indicated that the production of almost all
tested cytokines (IFN-, IL-6, TNF-, and IL-8) was inhibited
by the rIris/His cellular extract, except for IL-1 production,
which was unaffected after LPS stimulation (Table I). rIris/His
cellular extract inhibited IL-10 production by PMBCs after
PHA stimulation, and had no effect on PMBCs stimulated with
CD3/CD28 and LPS. The NEG cellular extract had no signifi-
cant effect on the cytokine production except after LPS stimu-
lation, which inhibited IL-10 production and enhanced IL-6
production. The dose-dependent effect of rIris/His was exam-
ined by analyzing the IFN-, IL-5, and IL-10 production under
CD3/CD28 and PPD stimulation (Fig. 4). In these cases, the
maximum inhibition of IFN- production by rIris/His was of
65% [the difference between rIris/His and NEG cellular ex-
tracts were statistically significant (p  0.01)] and 75% (p 
0.05) after CD3/CD28 and PPD stimulation, respectively. This
inhibition was still effective at a 1:12.5 dilution. In contrast, no
difference in the production of IL-5 and IL-10 was observed
between PBMCs incubated with rIris/His and NEG cellular
extracts.
To confirm the role of Iris in the modulation of the production
of some cytokines, PBMCs stimulated by CD3/CD28 activator
were incubated with various dilutions (from 1:250 to 1:4,000) of
anti-rIris/MBP serum (Fig. 5A). It was observed that PBMCs
treated with rIris/His cellular extract (at dilution 1:12.5) in the
presence of anti-rIris/MBP serum restored the IFN- produc-
tion in a dose-dependent manner (Fig. 5A), whereas this anti-
serum itself had no immunostimulating effect on cytokine pro-
duction by PBMCs (data not shown). At dilution of 1:250, the
antiserum re-established the IFN- production to a level sim-
ilar to that obtained by CD3/CD28-stimulated PBMCs without
rIris/His. To assert the specificity of the neutralizing activity of
the anti-rIris/MBP serum, its effect was measured on the ac-
tivity of cyclosporine A (CsA) (Fig. 5B), an immunosuppressive
drug. The effect of a serum specific to an unrelated MBP fusion
protein was also measured on rIris/His cellular extracts activ-
ity (Fig. 5A). The anti-rIris/MBP serum (at a 1:250 dilution) did
not affect the activity of 400 nM CsA, and the unrelated anti-
serum had no effect on the rIris/His immunomodulatory
activity.
Finally, a small amount of rIris/His was purified from the
rIris/His CHO-K1 cellular extract. This purified rIris/His pro-
tein, at a25 nM concentration, completely inhibited the IFN-
production by CD3/CD28-stimulated PBMCs (Fig. 5C), which
was partially restored (50% of the IFN- production by CD3/
CD28-stimulated PBMCs) by using anti-rIris/MBP serum (at
1:250 dilution). Interestingly, it was found that the level of
inhibition of 25 nM purified rIris/His was comparable with
that of 400 nM CsA. The incubation of CD3/CD28-stimulated
TABLE I
Cytokine production by PBMC treated with rIris/His cellular extract
Expression is inhibited () or unchanged (/). Values represent the
percentage of cytokine production calculated in comparison with cells
stimulated only with the activator.
Cell Stimulation
PHA CD3/CD28 PPD LPS
IFN-    
36% 46% 7% 43%
IL-8   
22% 12% 13%
IL-10  / / /
27% 97% 98% 116%
IL-6    
16% 16% 12% 10%
TNF- 
11%
IL-1 /
97%
FIG. 3. IFN- and IL-10 ELISPOT of human PBMCs. The number of activated cells producing the cytokines upon treatment with PHA or LPS
was evaluated (spots/106 cells  S.D.). Activated cells were counted after treatment with rIris/His or NEG cellular extracts. A positive control was
realized by stimulating the cells only with the activator (PHA or LPS).
4
PBMCs with either purified NEG and anti-rIris/MBP serum (at
1:250 dilution) or purified NEG alone had no influence on the
IFN- production.
DISCUSSION
It is now well established that the modulation of host immu-
nity by tick saliva is of major importance both in the successful
accomplishment of the blood meal and in the transmission of
tick-borne pathogens such as Borrelia burgdorferi, the causal
agent of Lyme disease (16). Although extensive information is
available on the effects of tick feeding on host immune de-
fenses, little is known about the nature of the immunomodu-
latory molecules expressed by tick salivary glands. Tick sali-
vary gland extracts (SGE) modulates host immune response by
modifying both lymphocyte and monocyte activities. For exam-
ple, T lymphocyte proliferation in response to mitogens (17)
and the production of Th1 cytokines as IFN- and IL-2 are
inhibited by SGE (18). Moreover, Th2 type cytokine production
such as IL-10, IL-5, and IL-4 is in general slightly enhanced (4,
5). Tick SGE also inhibits the production of several cytokines
(IFN-, IL-8, IL-6, TNF-, etc.) by human macrophages (19).
Studies indicated that some of those immunomodulating phe-
nomena are induced by proteins (20, 21).
In this work, we have characterized the properties of a pro-
tein induced during the tick feeding process, which is called Iris
for “I. ricinus immunosuppressor,” because of its exceptional
immune properties on leukocytes.
The corresponding mRNA sequence was first recovered by
analyzing a representational difference analysis subtractive
library, and by using the rapid amplification of cDNA ends
method (10). In this report, we show by Western blot and
confocal microscopy using a specific antiserum that Iris is not
only specifically expressed during the blood meal in female I.
ricinus salivary glands but is also present in saliva with an
increasing expression from day 3 to day 5 of engorgement. To
determine the immunomodulatory properties of Iris, we stud-
ied the effect of the corresponding recombinant protein (rIris/
FIG. 4. IFN- and IL-5 production
by human PBMCs. Cells were incubated
only with the activator (N.S.) or with var-
ious dilutions of rIris/His and NEG cellu-
lar extracts. The production of the cyto-
kines (concentration in pg/ml  S.D.) was
evaluated by ELISA after treatment with
CD3/CD28 or PPD.
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His) on naive Balb/c spleen cell proliferation, and on human
PBMCs cytokine production, using specific T lymphocytes
(PHA, ConA, CD3/CD28, and PMA/CD28), macrophages (LPS),
and APC (PPD) activators. The results indicated that rIris/His
cellular extracts inhibited in a dose-dependent manner the
proliferation of murine lymphocytes. ELISA and ELISPOT as-
says showed that the rIris/His cellular extracts suppressed the
production of IFN- by human T cell and APC, whereas IL-5
and IL-10 levels remained unchanged or were inhibited. In-
deed, rIris/His cellular extract inhibited IL-10 production by T
lymphocytes stimulated with PHA, but had no effect on CD3/
CD28-stimulated cells. In contrast, rIris/His extract enhanced
the number of macrophages producing IL-10 (see Fig. 3) and
had no effect on the expression of this cytokine by macrophages
(Table I). This difference could be explained by the low level of
IL-10 detected by ELISA, the high sensitivity (up to 200 times)
of the ELISPOT technique, and the variety in shape and size of
the spots observed with ELISPOT. Nevertheless, these results
suggest Iris does not inhibit the IL-10 production by macro-
phages. It was also shown that the expression of the pro-
inflammatory cytokine IL-6 was inhibited by macrophages, T
cells, and APC. In addition, the production of TNF- by macro-
phages was inhibited, whereas IL-1 expression remained un-
affected. Furthermore, by neutralizing completely rIris/His cel-
lular extract activity with a specific anti-rIris serum, and by
showing that purified rIris/His protein inhibited IFN- produc-
FIG. 5. IFN- production by human PBMCs stimulated with CD3/CD28. The cells were stimulated with NEG and rIris/His cellular
extracts at a 1:12.5 dilution. All the assays were realized by stimulating the cells, with CD3/CD28 only (P.C.), with CD3/CD28 in the presence of
NEG cellular extract (NEG), or with CD3/CD28 in the presence of rIris/His cellular extract (rIris/His). A, CD3/CD28 stimulated cells were
incubated with rIris/His cellular extract in the presence of various dilutions of either anti-rIris/MBP serum (Anti-rIris/MBPrIris/His) or a
nonspecific serum (ns AbrIris/His). B, CD3/CD28-stimulated cells were incubated with 400 nM CsA (CsA), with 400 nM CsA in the presence of
anti-rIris/MBP serum (CsA  Anti-rIris/MBP), or with 400 nM CsA and the nonspecific serum (CsA  NS AB); both antisera were used at a 1:250
dilution. C, CD3/CD28-stimulated PBMCs were also incubated with purified NEG (pNEG) or rIris/His (pIris/His) protein and with purified NEG
or rIris/His proteins in the presence of anti-rIris/MBP serum at a 1:250 dilution (pNEG  Anti-rIris/MBP and pIris/His  Anti-rIris/MBP).
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tion by T cell, we clearly established that the recombinant
protein was responsible for the immunomodulation. Impor-
tantly, the inhibitory effect of 25 nM rIris/His on IFN- pro-
duction (inhibition of 94%) is comparable with 400 nM CsA
activity (inhibition of 99%). This inhibition of IFN- production
suggests that the T cell proliferation is also inhibited. This
hypothesis was confirmed by showing that rIris/His protein
inhibited murine T cell proliferation. These observations indi-
cate that Iris is a novel immunosuppressor induced in the
salivary glands of engorged ticks during the blood meal. It
suppresses T lymphocyte proliferation and induces a Th2 type
immune response that is characterized by the inhibition of
IFN- production and an unaffected expression of IL-5 and
IL-10 by T lymphocytes and APC. Moreover, IL-10 production
by macrophages is not inhibited by Iris, confirming the pro-Th2
activity of Iris. In addition, Iris modulates the mechanisms of
innate immunity by inhibiting the production of pro-inflamma-
tory cytokines (IL-6 and TNF-).
It is known that several immunomodulatory factors are se-
creted in saliva at various times of the feeding process. Indeed,
SGE, prepared daily from engorging Dermacentor andersoni,
suppressed IL-1 secretion by macrophages only from day 0 to
day 5 of engorgement, whereas TNF- production was sup-
pressed during the entire blood meal by these cells (18). Except
for the fact that IL-1 expression is not inhibited, the modulat-
ing effect of Iris on T cell and macrophage responsiveness
seems to mimic the SGE properties, suggesting that Iris is an
important salivary factor in the modulation of the local host
immune response.
Finally, it is known that IL-4 produced following I. ricinus
tick bites strongly influences the immune response against B.
burgdorferi (22). Moreover, Th1 cytokines are down-regulated
during the initial spirochete transmission period in mice in-
fested with Ixodes scapularis-infected ticks (23). IFN-, TNF-,
and IL-2 given at the time of tick feeding suppress spirochete
transmission by I. scapularis (16). In addition, it has been
shown recently that this Th2 type immune response makes
possible the transmission of the human granulocytic ehrlichio-
sis agent (24). Consequently, based on its immune properties,
Iris could be a key factor facilitating the transmission of a large
number of tick borne pathogens.
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